AMEX:ELMD

Stock Analysis Report

Executive Summary

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of all ages in the United States and internationally.


Snowflake Analysis

Flawless balance sheet with solid track record.


Similar Companies

Share Price & News

How has Electromed's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ELMD's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-3.2%

ELMD

-7.5%

US Medical Equipment

-7.6%

US Market


1 Year Return

121.7%

ELMD

10.7%

US Medical Equipment

10.2%

US Market

Return vs Industry: ELMD exceeded the US Medical Equipment industry which returned 10.7% over the past year.

Return vs Market: ELMD exceeded the US Market which returned 10.2% over the past year.


Shareholder returns

ELMDIndustryMarket
7 Day-3.2%-7.5%-7.6%
30 Day17.9%-6.6%-4.5%
90 Day18.3%-2.3%-0.6%
1 Year121.7%121.7%11.6%10.7%12.5%10.2%
3 Year133.2%133.2%64.4%59.8%37.1%28.3%
5 Year400.4%400.4%98.6%77.8%60.8%43.2%

Price Volatility Vs. Market

How volatile is Electromed's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Electromed undervalued compared to its fair value and its price relative to the market?

26.84x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: ELMD ($11.66) is trading above our estimate of fair value ($10.91)

Significantly Below Fair Value: ELMD is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ELMD is good value based on its PE Ratio (26.8x) compared to the Medical Equipment industry average (45.3x).

PE vs Market: ELMD is poor value based on its PE Ratio (26.8x) compared to the US market (17.1x).


Price to Earnings Growth Ratio

PEG Ratio: ELMD is poor value based on its PEG Ratio (3.1x)


Price to Book Ratio

PB vs Industry: ELMD is good value based on its PB Ratio (3.5x) compared to the US Medical Equipment industry average (3.9x).


Next Steps

Future Growth

How is Electromed forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

8.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ELMD's forecast earnings growth (8.6% per year) is above the savings rate (1.7%).

Earnings vs Market: ELMD's earnings (8.6% per year) are forecast to grow slower than the US market (13.2% per year).

High Growth Earnings: ELMD's earnings are forecast to grow, but not significantly.

Revenue vs Market: ELMD's revenue (12.2% per year) is forecast to grow faster than the US market (7.6% per year).

High Growth Revenue: ELMD's revenue (12.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ELMD's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Electromed performed over the past 5 years?

17.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ELMD has high quality earnings.

Growing Profit Margin: ELMD's current net profit margins (11.1%) are higher than last year (6.2%).


Past Earnings Growth Analysis

Earnings Trend: ELMD's earnings have grown by 17.7% per year over the past 5 years.

Accelerating Growth: ELMD's earnings growth over the past year (94.4%) exceeds its 5-year average (17.7% per year).

Earnings vs Industry: ELMD earnings growth over the past year (94.4%) exceeded the Medical Equipment industry 1.4%.


Return on Equity

High ROE: ELMD's Return on Equity (12.8%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Electromed's financial position?


Financial Position Analysis

Short Term Liabilities: ELMD's short term assets ($26.3M) exceed its short term liabilities ($3.0M).

Long Term Liabilities: ELMD's short term assets ($26.3M) exceed its long term liabilities ($39.6K).


Debt to Equity History and Analysis

Debt Level: ELMD is debt free.

Reducing Debt: ELMD has no debt compared to 5 years ago when its debt to equity ratio was 9.4%.

Debt Coverage: ELMD has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ELMD has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: ELMD has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if ELMD's debt is covered by short term assets.


Next Steps

Dividend

What is Electromed's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%4.0%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate ELMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ELMD's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ELMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ELMD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ELMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average management tenure


CEO

Kathleen Skarvan (63yo)

7.2yrs

Tenure

US$867,573

Compensation

Ms. Kathleen S. Skarvan has been the Chief Executive Officer of Electromed, Inc. since December 1, 2012 and its President since August 28, 2015. Ms. Skarvan served as Vice President of Operations at OEM Fa ...


CEO Compensation Analysis

Compensation vs Market: Kathleen's total compensation ($USD867.57K) is above average for companies of similar size in the US market ($USD529.87K).

Compensation vs Earnings: Kathleen's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Kathleen Skarvan
CEO, President & Director7.2yrsUS$867.57k1.52% $1.5m
Jeremy Brock
CFO, Principal Accounting Officer & Financial Controller8.3yrsUS$463.32k0.62% $612.2k
Bud Reeves
VP of Sales0.8yrsno datano data
William George
Secretary0yrsno datano data
Kathryn Thompson
Vice President of Reimbursement2.3yrsno datano data

4.8yrs

Average Tenure

63yo

Average Age

Experienced Management: ELMD's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kathleen Skarvan
CEO, President & Director7.2yrsUS$867.57k1.52% $1.5m
Lee Jones
Independent Director5.5yrsUS$24.60k0.21% $212.0k
Gregory Fluet
Independent Director0.5yrsno data0.035% $35.0k
Stan Erickson
Independent Vice Chairman of the Board3.1yrsUS$32.40k0.25% $242.7k
George Winn
Independent Director15.1yrsUS$23.60k7.21% $7.1m
Stephen Craney
Independent Chairman7.8yrsUS$45.90k6.66% $6.6m
Anne O'Donnell
Member of Bronchiectasis Advisory Board2.5yrsno datano data
Chad Marion
Member of Bronchiectasis Advisory Board2.5yrsno datano data
Peadar Noone
Member of Bronchiectasis Advisory Board2.5yrsno datano data

3.1yrs

Average Tenure

65.5yo

Average Age

Experienced Board: ELMD's board of directors are considered experienced (3.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Electromed, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Electromed, Inc.
  • Ticker: ELMD
  • Exchange: AMEX
  • Founded: 1992
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$98.859m
  • Shares outstanding: 8.48m
  • Website: https://www.smartvest.com

Number of Employees


Location

  • Electromed, Inc.
  • 500 Sixth Avenue NW
  • New Prague
  • Minnesota
  • 56071
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ELMDAMEX (NYSE MKT LLC)YesCommon StockUSUSDAug 2010

Biography

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/27 02:22
End of Day Share Price2020/02/26 00:00
Earnings2019/12/31
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.